🇺🇸 FDA
Pipeline program

18F-PSMA-1007

37587411

Unknown small_molecule active

Quick answer

18F-PSMA-1007 for Multiple Myeloma is a Unknown program (small_molecule) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).

Program details

Company
China SXT Pharmaceuticals
Indication
Multiple Myeloma
Phase
Unknown
Modality
small_molecule
Status
active

Clinical trials